Xiaobin Lv
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Geriatrics and Gerontology top 10%
- Sirtuins and Resveratrol in Medicine
Papers in
-
- MicroRNA in disease regulation 2
- Cancer-related molecular mechanisms research 2
- Cancer, Hypoxia, and Metabolism 1
- Oncology 3
- Cancer-related Molecular Pathways 2
- Co-authors
- Yi Sang (3 shared papers)Lei Zeng (2 shared papers)Chun Cheng (2 shared papers)Jianjun Tang (2 shared papers)Yinghua Zhu (3 shared papers)Junjun Chu (3 shared papers)Qiannan Guo (3 shared papers)Yanqing Wu (3 shared papers)
- Journals
- Oncotarget (3 papers)Journal of Molecular Medicine (1 paper)Oncology Reports (1 paper)Cancer Research (1 paper)Oncogene (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Xiaobin Lv
10 papers receiving 505 citations
Peers
Comparison fields: 5 of 54
- Cancer Research 214
- Geriatrics and Gerontology 25
- Molecular Biology 204
- Oncology 50
- Otorhinolaryngology 9
Countries citing papers authored by Xiaobin Lv
This map shows the geographic impact of Xiaobin Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobin Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobin Lv more than expected).
Fields of papers citing papers by Xiaobin Lv
This network shows the impact of papers produced by Xiaobin Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobin Lv. The network helps show where Xiaobin Lv may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaobin Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 129 | |
| 2 | 2015 | 82 | |
| 3 | 2015 | 77 | |
| 4 | 2011 | 48 | |
| 5 | 2016 | 48 | |
| 6 | 2018 | 46 | |
| 7 | 2014 | 31 | |
| 8 | 2015 | 20 | |
| 9 | 2017 | 17 | |
| 10 | 2023 | 12 |
About Xiaobin Lv
Xiaobin Lv is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Molecular Biology and Biotechnology, having authored 10 papers that have together received 510 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (3 papers), Cancer-related Molecular Pathways (2 papers), MicroRNA in disease regulation (2 papers), Cancer-related molecular mechanisms research (2 papers), Cancer, Hypoxia, and Metabolism (1 paper), Neonatal Health and Biochemistry (1 paper), Immune cells in cancer (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Cancer Research (214 citations), Geriatrics and Gerontology (25 citations), Molecular Biology (204 citations), Oncology (50 citations) and Otorhinolaryngology (9 citations). Xiaobin Lv has collaborated with scholars based in China and United States. Frequent co-authors include Yi Sang, Lei Zeng, Chun Cheng, Jianjun Tang, Yinghua Zhu, Junjun Chu, Qiannan Guo, Yanqing Wu, Kaishun Hu and Bentong Yu. Their work appears in journals such as Oncotarget, Journal of Molecular Medicine, Oncology Reports, Cancer Research and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.